![Mark Meltz](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Mark Meltz
General Counsel at
LYELL IMMUNOPHARMA, INC.
Profile
Mark Adam Meltz is Secretary & General Counsel at Lyell Immunopharma, Inc. since 2025.
Formerly, Mr. Meltz was COO, Secretary, Treasurer & General Counsel at Kinnate Biopharma, Inc. from 2020 to 2024; Senior Vice President & General Counsel at Astellas Gene Therapies, Inc. from 2019 to 2020; Chief Business Development & Legal Officer at Emergent Travel Health, Inc. from 2014 to 2019; Associate General Counsel at Biogen, Inc. from 2007 to 2012; Counsel at BMC Partners LLP; and Head-North & Latin America Legal Division at Novartis Vaccines & Diagnostics, Inc. Education includes undergraduate studies at Yale University and graduate studies at Boston College Law School.
Mark Meltz active positions
| Companies | Position | Start |
|---|---|---|
| LYELL IMMUNOPHARMA, INC. | General Counsel | 2025-06-08 |
Former positions of Mark Meltz
| Companies | Position | End |
|---|---|---|
| KINNATE BIOPHARMA INC. | Director of Finance/CFO | 2021-06-06 |
| AUDENTES THERAPEUTICS, INC. | General Counsel | 2020-01-31 |
Emergent Travel Health, Inc.
 Emergent Travel Health, Inc. BiotechnologyHealth Technology Provides biotechnical research services | General Counsel | 2019-02-28 |
| BIOGEN INC. | General Counsel | 2012-02-29 |
BMC Partners LLP
 BMC Partners LLP Miscellaneous Commercial ServicesCommercial Services Provides legal services | Corporate Officer/Principal | - |
Training of Mark Meltz
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
69
1st degree connections
9
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 9 |
|---|---|
Biogen, Inc.
 Biogen, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets therapies for neurological and neurodegenerative diseases | Health Technology |
Emergent Travel Health, Inc.
Emergent Travel Health, Inc. BiotechnologyHealth Technology Provides biotechnical research services | Health Technology |
BMC Partners LLP
BMC Partners LLP Miscellaneous Commercial ServicesCommercial Services Provides legal services | Commercial Services |
Yale University
 Yale University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Novartis Vaccines & Diagnostics, Inc.
 Novartis Vaccines & Diagnostics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets health care and nutritional products | Health Technology |
Astellas Gene Therapies, Inc.
 Astellas Gene Therapies, Inc. BiotechnologyHealth Technology Develops and commercializes gene therapy products for patients with serious rare diseases | Health Technology |
Boston College Law School
 Boston College Law School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Lyell Immunopharma, Inc.
 Lyell Immunopharma, Inc. BiotechnologyHealth Technology Develops cell-based immunotherapies for human diseases | Health Technology |
Kinnate Biopharma, Inc.
 Kinnate Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage precision oncology company | Health Technology |
- Stock Market
- Insiders
- Mark Meltz
Choose MarketScreener 
